()201412823ChinJClinicians(ElectronicEdition),December1,2014,Vol.8,No.234251WHO[1]WHO1.EQAAFB2.1EQAAFBHIV1%HIV5%2XHIVHIVHIV6050kg10mg/kg[2][3]DOI:10.3877/cma.j.issn.1674-0785.2014.23.020266012Email:lindoc@126.com1.162HRZE/4HR2HRZE/6HE26[4]2[2HRZE/4HR3][2HRZE3/4HR3]HIV32.HREHR3.1232HRZES/1HRZE/5HRE4()201412823ChinJClinicians(ElectronicEdition),December1,2014,Vol.8,No.23 42521233351.[5]2.HIV1HIV23HIVHIV3.HIV[6]HIV[7]HIV8HIV2[8]12233334/45/5144123412()201412823ChinJClinicians(ElectronicEdition),December1,2014,Vol.8,No.23425315112233445557236418249129319HRE2HREV/6HR6-9RZE22HEV/10HE318242HRZE/4ZE15mg/kg25mg/kg15mg/kg[1]Treatmentoftuberculosis:guidelinesfornationalprogrammes[S].3rded.Geneva:WorldHealthOrganization,2003(WHO/CDS/TB/2003.313).[2]AmericanThoracicSociety,CDC,InfectiousDiseasesSocietyofAmerica.Treatmentoftuberculosis[J].MorbidityandMortalityWeeklyReport:RecommendationsandReports,2003,52(RR-11):1-77.[3],,,.[J].,2014,7(23):444.[4]MenziesD.Effectofdurationandintermittencyofrifampinontuberculosistreatmentout-comes:asystematicreviewandmeta-analysis[J].PloSMedicine,2009,6:e1000146.[5],,,.[M].:,2006:436-437.[6]WellsCD.HIVinfectionandmultidrug-resistanttuberculosis:theperfectstorm[J].JournalofInfectiousDiseases,2007,196(Suppl1):S86-S107.[7]Guidelinesonco-trimoxazoleprophylaxisforHIV-relatedinfectionsamongchildren,adolescentsandadultsinresource-limitedsettings:recommendationsforapublichealthapproach[S].Geneva:WorldHealthOrganization,2006.[8]HarriesAD,ZachariahR,LawnSD.ProvidingHIVcareforco-infectedtuberculosispa-tients:aperspectivefromsub-SaharanAfrica[J].InternationalJournalofTuberculosisandLungDisease,2009,13:6-16.2014-10-17.WHOJ/CD.20148234251-4253.